Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06407167
Other study ID # NS12-02
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 13, 2024
Est. completion date May 13, 2026

Study information

Verified date May 2024
Source N.N. Priorov National Medical Research Center of Traumatology and Orthopedics
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Pre- and postoperative pain in patients with degenerative stenosis requires great attention, as it can mislead the doctor about treatment tactics. Neuropathic pain in the legs before and after the surgical procedure, as well as the residual or recurrent pain syndrome existing against this background, overshadow the patient's recovery and cast doubt on the fullness of the performed decompression. Neural compression in the spinal canal and back pain may be the cause of the patient's antalgic posture and sagittal imbalance as seen on X-Ray, to need for corrective interventions surgical procedure. Thus, it is necessary to clarify the role and the influence of the pain and its type on the perioperative period in patients with degenerative lumbar spinal stenosis.


Description:

The current study is prospective observational study to evaluate the role of pain syndrome including neuropathic pain in surgical outcomes in patients with degenerative lumbar spinal stenosis. This study will be conducted at Priorov Central Institute for Trauma and Orthopedics, Moscow, Russia. The study is expected to enroll at least 120 adult patients with degenerative lumbar stenosis. The neuropathy will be assessed preoperatively, and then the patient will undergo decompressive lumbar surgery without fusion. The neuropathic pain will be evaluated according to DN4 preoperatively, each patient will be assigned to one of two groups depending on the total value of DN4 - with the presence of neuropathy (DN4>= 4) and without neuropathy (DN4 <4). Postoperative evaluation will include 2 visits during one year to evaluate clinical and radiological outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date May 13, 2026
Est. primary completion date May 13, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Age 18-85 years; 2. Radicular leg pain with or without neurogenic claudication with or without back pain; 3. Planned decompressive surgery for degenerative lumbar stenosis with or without degenerative spondylolisthesis; 4. Symptoms persisting for at least 3 months prior to surgery; 5. Given written Informed Consent; 6. Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements Exclusion Criteria: 1. Prior lumbar fusion at any level; 2. Any contraindication or inability to undergo baseline and/or follow up MRI or X-ray as required per protocol; 3. Back or non-radicular pain of unknown etiology; 4. History or presence of any other major neurological disease or condition that may interfere with the study assessments (e.g. significant peripheral neuropathy, multiply sclerosis); 5. Any other condition or situation that the investigator believes may interfere with the safety of the subject or the intent and conduct of the study; 6. Previous enrollment in this study, current enrollment or plans to be enrolled in another study (in parallel to this study).

Study Design


Intervention

Diagnostic Test:
DN4 (Douleur Neuropathique 4 Questions) questionnaire
DN4 includes a series of ten questions consisting of both sensory descriptors and signs related to bedside sensory examination

Locations

Country Name City State
Russian Federation Priorov National Medical Research Center of Traumatology and Orthopedics Moscow

Sponsors (1)

Lead Sponsor Collaborator
N.N. Priorov National Medical Research Center of Traumatology and Orthopedics

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in Oswestry Disability Index (ODI) To observe the change of Oswestry Disability Index as compared to baseline through follow-up terms 3 months postoperatively
Secondary Change from baseline in Neuropathic Pain 4 Questions (DN4) To observe the change of Neuropathic Pain 4 Questions as compared to baseline through follow-up terms 2 weeks (or at day of hospital discharge), 3 months, 12 months postoperatively
Secondary Change from baseline in Numeric Pain Rating Scale (NPRS) To observe the change of Numeric Pain Rating Scale as compared to baseline through follow-up terms 2 weeks (or at day of hospital discharge), 3 months, 12 months postoperatively
Secondary Change from baseline in Oswestry Disability Index (ODI) To observe the change of Oswestry Disability Index as compared to baseline through follow-up terms 12 months postoperatively
Secondary Change from baseline in The Health Transition Item from SF-36 (HTI Item) To observe the change of The Health Transition Item as compared to baseline through follow-up terms 2 weeks (or at day of hospital discharge), 3 months, 12 months postoperatively
Secondary Change from baseline in sagittal balance parameters To observe the change of sagittal balance parameters (index Barrey) as compared to baseline through follow-up terms 3 months, 12 months postoperatively
Secondary Change from baseline in regional balance parameters To observe the change of regional balance parameters (Segmental Lordosis) as compared to baseline through follow-up terms 3 months, 12 months postoperatively
Secondary Change from baseline in frontal balance parameters To observe the change of frontal balance parameters (Cobb's angle) as compared to baseline through follow-up terms 3 months, 12 months postoperatively
Secondary the safety parameters To observe and document the safety parameters (Adverse events) during study, an average of 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT04699734 - Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Completed NCT05235191 - Effectiveness and Safety of Methadone Versus Placebo for the Control of Neuropathic Pain in Different Etiologies Phase 3
Completed NCT05845177 - Persistent Pain After Hip Replacement
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Not yet recruiting NCT05949554 - Electroencephalographic (EEG) Profils for Patients on Intravenous Ketamine.
Withdrawn NCT05052645 - Ear Acupuncture for Neuropathic Pain N/A
Completed NCT02824588 - Working Memory Training for Chronic Neuropathic and Fibromyalgia Pain N/A
Completed NCT02866396 - Impact of Pregabalin in Chronic Users vs. a Perioperative Limited Prescription on Oxycodone Requirement
Completed NCT02930551 - Neuromas as the Cause of Pain N/A
Active, not recruiting NCT02560545 - Cannabinoids Effects on the Pain Modulation System N/A
Enrolling by invitation NCT02485795 - Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management N/A
Completed NCT02099890 - The Effect of Diet on Chronic Inflammation and Related Disorders Following Spinal Cord Injury Phase 3
Not yet recruiting NCT02246517 - The Effect of N2O on Chronic Neuropathic Pain Patients Phase 0
Completed NCT01946555 - Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain N/A
Completed NCT01884662 - Virtual Walking for Neuropathic Pain in Spinal Cord Injury N/A
Completed NCT01718821 - Assessments on Current Pain Managements in Upper Gastrointestinal Cancer Patients N/A
Completed NCT01669967 - The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin N/A
Completed NCT01207596 - Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain Phase 4
Completed NCT01201317 - A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy Phase 2